Prostate microcalcification crystallography as a marker of pathology

Area of Science:

• Oncology
• Materials Science
• Biochemistry

Background:

• Prostate cancer is the most common male cancer, with treatment decisions complicated by inconsistent diagnostic methods.
• Novel biomarkers are needed to improve patient counseling and treatment strategies for prostate cancer.
• Prostate calcifications represent a potential, unexplored avenue for biomarker discovery.

Purpose of the Study:

• To investigate the chemical composition and crystallographic properties of prostate calcifications.
• To explore the correlation between prostate calcification characteristics and clinical markers of prostate cancer, such as Gleason Grade (GG) and pathological stage.
• To assess the potential of prostate calcifications as novel biomarkers for prostate cancer.

Main Methods:

• Microfocus spectroscopy was employed at the i18 beamline (Diamond Light Source) to analyze calcifications in prostate tissue sections.
• X-ray diffraction and fluorescence mapping were used to determine the composition and lattice parameters of calcifications.
• Statistical analysis (Kendall's Tau) was performed to correlate calcification properties with GG and pathological stage.

Main Results:

• Prostate calcifications were predominantly composed of hydroxyapatite (HAP) and whitlockite (WH).
• Weak correlations were observed between HAP lattice parameters and GG, and between zinc levels and GG.
• Negative correlations were found between HAP and WH lattice parameters and pathological stage.

Conclusions:

• The chemical and crystallographic properties of prostate calcifications correlate with key clinical indicators of prostate cancer.
• These findings suggest that prostate calcifications have significant potential as novel biomarkers.
• Further research into calcification biomarkers could lead to improved diagnostic and prognostic tools for prostate cancer management.